Neuroscientific Biopharmaceuticals Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -0.029x

Neuroscientific Biopharmaceuticals Ltd cash flow conversion efficiency. Based on the latest financial reports, Neuroscientific Biopharmaceuticals Ltd (NSB) has a cash flow conversion efficiency ratio of -0.029x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-480.55K ≈ $-340.02K USD) by net assets (AU$16.81 Million ≈ $11.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Neuroscientific Biopharmaceuticals Ltd (2016–2025)

Cash flow conversion efficiency of Neuroscientific Biopharmaceuticals Ltd from 2016 to 2025. This chart illustrates how Neuroscientific Biopharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NSB share price today for real-time trading data and today's change.

Neuroscientific Biopharmaceuticals Ltd Cash Flow Conversion Ratio Explained

Neuroscientific Biopharmaceuticals Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Neuroscientific Biopharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neuroscientific Biopharmaceuticals Ltd ranked by their cash flow conversion efficiency. Also see NSB company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Prizma Pres Matbaacilik Yayincilik Sanayi ve Ticaret AS IS:PRZMA	0.007x
Seker Finansal Kiralama AS IS:SEKFK	-0.039x
Yong Tai Bhd KLSE:7066	0.005x
FACILITIES BY ADF LS-01 F:ZC8	N/A
Encorp Bhd KLSE:6076	0.112x
Playtech Plc LSE:PTEC	-0.001x
Digital Graphics Incorporation KQ:043360	0.007x
Park Ha Biological Technology Co., Ltd. NASDAQ:BYAH	N/A

Annual Cash Flow Conversion Efficiency for Neuroscientific Biopharmaceuticals Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Neuroscientific Biopharmaceuticals Ltd from 2016 to 2025. Review NSB free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$16.81 Million ≈ $11.90 Million	AU$-941.33K ≈ $-666.05K	-0.056x	-776.94%
2024-06-30	AU$5.35 Million ≈ $3.79 Million	AU$44.25K ≈ $31.31K	0.008x	+101.68%
2023-06-30	AU$4.69 Million ≈ $3.32 Million	AU$-2.30 Million ≈ $-1.63 Million	-0.491x	+60.97%
2022-06-30	AU$5.52 Million ≈ $3.91 Million	AU$-6.94 Million ≈ $-4.91 Million	-1.258x	-606.05%
2021-06-30	AU$14.60 Million ≈ $10.33 Million	AU$-2.60 Million ≈ $-1.84 Million	-0.178x	+71.50%
2020-06-30	AU$3.65 Million ≈ $2.58 Million	AU$-2.28 Million ≈ $-1.61 Million	-0.625x	-124.79%
2019-06-30	AU$5.06 Million ≈ $3.58 Million	AU$-1.41 Million ≈ $-995.83K	-0.278x	+59.09%
2018-06-30	AU$732.52K ≈ $518.30K	AU$-497.91K ≈ $-352.30K	-0.680x	-95.36%
2017-06-30	AU$535.79K ≈ $379.10K	AU$-186.42K ≈ $-131.90K	-0.348x	+50.65%
2016-06-30	AU$124.47K ≈ $88.07K	AU$-87.76K ≈ $-62.09K	-0.705x	--

About Neuroscientific Biopharmaceuticals Ltd

AU:NSB Australia Biotechnology

Market Cap

$12.71 Million

AU$17.96 Million AUD

Market Cap Rank

#26298 Global

#1177 in Australia

Share Price

AU$0.05

Change (1 day)

+3.85%

52-Week Range

AU$0.05 - AU$0.17

All Time High

AU$0.52